BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News
Emcure Pharmaceuticals Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
544210
ISIN Demat
INE168P01015
Book Value (Rs)
169.4916517
NSE Symbol
EMCURE
Divident Yield %
0.21
Market Cap
(Rs In Cr.)
26,823
P/E (TTM)
40.37
EPS (TTM)
35.05
Face Value
(Rs)
10
Date Heading
09-Mar-26 Volumes soar at Sonata Software Ltd counter
02-Mar-26 Emcure Pharmaceuticals signs distribution agreement with Roche
04-Feb-26 Emcure Pharmaceuticals consolidated net profit rises 49.97% in the Dec
23-Jan-26 Emcure Pharmaceuticals to announce Quarterly Result
24-Dec-25 Indices edge higher in early trade; breadth strong
22-Dec-25 Emcure launches semaglutide injection Poviztra® in India
18-Nov-25 Volumes spurt at Mphasis Ltd counter
11-Nov-25 Emcure Pharmaceuticals consolidated net profit rises 25.13% in the Sep
10-Nov-25 Novo Nordisk India partners with Emcure launch Poviztra® in India
04-Nov-25 Emcure Pharmaceuticals to hold board meeting
28-Oct-25 Volumes jump at Aditya Birla Capital Ltd counter
17-Oct-25 Emcure Pharmaceuticals Ltd - Announcement under Regulation 30 (LODR)-C
10-Oct-25 Emcure Pharmaceuticals' Kadu unit clears USFDA inspection
08-Oct-25 Emcure Pharmaceuticals Ltd - Emcure Pharmaceuticals Limited - Updates
07-Oct-25 Emcure Pharmaceuticals Ltd - Emcure Pharmaceuticals Limited - Updates
Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)